Title {1}	Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial
Trial registration {2a and 2b}	ClinicalTrials.gov, NCT03850912. Registered on February 22, 2019. Last updated on November 9, 2021.
Protocol version {3}	Protocol version 7.0; January 12, 2022.
Funding {4}	This research is supported by the National Cancer Institute of the National Institutes of Health; 1UM1CA233080-01.
Author details {5a}	Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Boston, MA (Hassett, Uno, Cronin) Maine Medical Center, Portland, ME (Bian) Lifespan Cancer Institute and Brown University, Providence, RI (Dizon) West Virginia University Cancer Center, Morgantown, WV (Hazard Jenkins) Baptist Medical Center, Memphis, TN (Osarogiagbon) Dartmouth Hitchcock Medical Center, Lebanon, NH (Wong) Memorial Sloan Kettering Cancer Center, New York, NY (Schrag)
Name and contact information for the trial sponsor {5b}	This research is supported by the National Cancer Institute of the National Institutes of Health; 1UM1CA233080-01.
Role of sponsor {5c}	The content of this protocol paper is solely the responsibility of the authors. It does not necessarily reflect the official views of the National Institutes of Health.